Business Standard

India Coronavirus Dispatch: Doctors are keen on Plasma despite ICMR move

Covaxin phase-III trials soon, medical grade oxygen supply may shrink, and is Covid airborne?--news on how the country is coping with the pandemic

Coronavirus
Premium

A health worker collects a nasal sample from a woman for a Rapid Antigen Test (RAT) for the Covid-19 coronavirus in Srinagar on Thursday.

Shreegireesh Jalihal New Delhi
Why doctors are keen on Plasma: ICMR chief said last week that plasma therapy could be removed from the list of Clinical Management Protocols for Covid-19. Despite this, its demand  continues full steam. Currently, plasma therapy is an investigational therapy permitted “off label”, meaning for unapproved use outside trial settings. Doctors say the therapy produces genuine results, in contradiction to the findings of a ICMR study. The study itself has been criticised over procedural shortcomings. Experts also point out that the study was conducted on patients in the ‘moderate stage’ of the disease. But the fact remains that the rise

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in